Avicor Ltd. successfully developed several new products in the frame of a Hungarian R&D grant (KFI_16-1-2017-0105) for specific enrichment of nucleic acids deriving from diverse biological samples specific for human, bacterial, fungal and viral nucleic acids.2020-02-19
Avicor at BIO 2019- Philadelphia, PA (June, 3-6 2019)2019-05-02
Avicor’s highly effective fluorophore AC-202 in Biotechnologies for Biofuels Journal2018-04-23
AVICOR was established in 2005 based on a patent portfolio covering the application of chemically modified solid surfaces for chemical microarray production and affinity bead preparation. Avicor is a service provider with clients from Europe and US big pharma and medium size companies. Avicor offers fully-integrated contract research, discovery and development services including drug discovery, target identification, and analytics.